Cerecin is a startup based in the United States, most recent round Series A, 1 tracked investor.
Based in the United States, Cerecin is a startup founded in 2015. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
A clinical-stage biotechnology company pioneering a new class of brain metabolism-based therapeutics for neurological and metabolic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.